4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-14-003323
CIK 0000887247operating
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 5:01 PM ET
Size
5.7 KB
Accession
0001387131-14-003323
Insider Transaction Report
Form 4
ROTHERMEL ROBERT B
Director
Transactions
- Award
Employee Stock Option (right to buy)
2014-09-24+47,058→ 50,000 totalExercise: $4.56Exp: 2024-09-25→ Common Stock (47,058 underlying)
Footnotes (1)
- [F1]The option vests monthly over a period of three (3) years commencing on August 25, 2014, the date on which the reporting person became a director of the Company. The option is granted pursuant to the Company's 2009 Equity Incentive Plan and is subject to other provisions as are set forth in the option agreement relating to such grant under the plan.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 5:01 PM ET
- Size
- 5.7 KB